» Articles » PMID: 23864310

An Index to Identify Stroke-related Vs Incidental Patent Foramen Ovale in Cryptogenic Stroke

Abstract

Objective: We aimed to create an index to stratify cryptogenic stroke (CS) patients with patent foramen ovale (PFO) by their likelihood that the stroke was related to their PFO.

Methods: Using data from 12 component studies, we used generalized linear mixed models to predict the presence of PFO among patients with CS, and derive a simple index to stratify patients with CS. We estimated the stratum-specific PFO-attributable fraction and stratum-specific stroke/TIA recurrence rates.

Results: Variables associated with a PFO in CS patients included younger age, the presence of a cortical stroke on neuroimaging, and the absence of these factors: diabetes, hypertension, smoking, and prior stroke or TIA. The 10-point Risk of Paradoxical Embolism score is calculated from these variables so that the youngest patients with superficial strokes and without vascular risk factors have the highest score. PFO prevalence increased from 23% (95% confidence interval [CI]: 19%-26%) in those with 0 to 3 points to 73% (95% CI: 66%-79%) in those with 9 or 10 points, corresponding to attributable fraction estimates of approximately 0% to 90%. Kaplan-Meier estimated stroke/TIA 2-year recurrence rates decreased from 20% (95% CI: 12%-28%) in the lowest Risk of Paradoxical Embolism score stratum to 2% (95% CI: 0%-4%) in the highest.

Conclusion: Clinical characteristics identify CS patients who vary markedly in PFO prevalence, reflecting clinically important variation in the probability that a discovered PFO is likely to be stroke-related vs incidental. Patients in strata more likely to have stroke-related PFOs have lower recurrence risk.

Citing Articles

Incorporation of robotic automated transcranial Doppler to screen for patent foramen ovale (PFO) and quantify right-to-left shunt severity in the evaluation of ischemic stroke patients for etiology and PFO management.

Chang I, Pirahanchi Y, Izaguirre S, Rodriguez R, Wicknick A Front Neurol. 2025; 15:1481817.

PMID: 40017730 PMC: 11866324. DOI: 10.3389/fneur.2024.1481817.


Cryptogenic stroke and patent foramen ovale: endeavoring for clarity.

Amini T Front Neurol. 2025; 15:1533232.

PMID: 39877404 PMC: 11772196. DOI: 10.3389/fneur.2024.1533232.


Multimodal data-based longitudinal prognostic model for predicting atrial fibrillation recurrence after catheter ablation in patients with patent foramen ovale and paroxysmal atrial fibrillation.

Duan S, Li X, Wang J, Wang Y, Xu T, Guo F Eur J Med Res. 2025; 30(1):39.

PMID: 39833853 PMC: 11748319. DOI: 10.1186/s40001-025-02286-z.


How Old is Too Old? Closure of Patent Foramen Ovale in Older Patients.

Vazquez-Sosa C, Clegg S, Blankenship J US Cardiol. 2024; 15:e20.

PMID: 39720499 PMC: 11664777. DOI: 10.15420/usc.2020.40.


Bilateral thalamic infarction with posterior cerebral artery variant (the arcade artery): A case report.

Ling L, Xu L, Zhou Y Medicine (Baltimore). 2024; 103(51):e40991.

PMID: 39705463 PMC: 11666220. DOI: 10.1097/MD.0000000000040991.


References
1.
Rodes-Cabau J, Noel M, Marrero A, Rivest D, Mackey A, Houde C . Atherosclerotic burden findings in young cryptogenic stroke patients with and without a patent foramen ovale. Stroke. 2008; 40(2):419-25. DOI: 10.1161/STROKEAHA.108.527507. View

2.
Jones Jr H, Caplan L, Come P, Swinton Jr N, Breslin D . Cerebral emboli of paradoxical origin. Ann Neurol. 1983; 13(3):314-9. DOI: 10.1002/ana.410130315. View

3.
Kent D, Hayward R . Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA. 2007; 298(10):1209-12. DOI: 10.1001/jama.298.10.1209. View

4.
Di Tullio M, Homma S, Jin Z, Sacco R . Aortic atherosclerosis, hypercoagulability, and stroke the APRIS (Aortic Plaque and Risk of Ischemic Stroke) study. J Am Coll Cardiol. 2008; 52(10):855-61. PMC: 2854145. DOI: 10.1016/j.jacc.2008.04.062. View

5.
Mas J, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G . Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001; 345(24):1740-6. DOI: 10.1056/NEJMoa011503. View